Immunometabolism: a new dimension in immunotherapy resistance
Chaoyue Xiao(Central South University), Fang Wu(Central South University), Yurong Peng(Central South University), Yue Zeng(Shandong University), Chunhong Hu(Central South University), Wei Xiong(Central South University), Junqi Liu(University of Minnesota), Jian Zou(Central South University), Yiting Xu(Central South University)
Cited by 15
Related Papers
Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study
|The Lancet Oncology|2011|4.1k
Circular RNAs function as ceRNAs to regulate and control human cancer progression
|Molecular Cancer|2018|1.1k
Neoantigen vaccine: an emerging tumor immunotherapy
|Molecular Cancer|2019|718
Emerging role of tumor-related functional peptides encoded by lncRNA and circRNA
|Molecular Cancer|2020|578
Circular RNAs in human cancer
|Molecular Cancer|2017|527